Phase 3 Study to Evaluate Intravenous Trappsol(R) Cyclo(TM) in Pediatric and Adult Patients With Niemann-Pick Disease Type C1

NCT04860960 · clinicaltrials.gov ↗

PHASE3

Phase

ACTIVE_NOT_RECRUITING

Status

94

Enrollment

INDUSTRY

Sponsor class

Conditions

Niemann-Pick Disease, Type C1

Interventions

DRUG: Hydroxypropyl-beta-cyclodextrin
DRUG: Placebo

Sponsor

Cyclo Therapeutics, Inc.